2006 will stand as a watershed year for CAD. Mammography and lung solutions were evident on the show floor; however, new applications covering multiple organ systems took a fair share of the spotlight. ìIn three years it will be hard imagine an image coming through a hospital without some type of CAD applied,î predicts Dave Faller, general manager of Kodak's CAD business. The first enterprise lung CAD solution that brings CAD to the PACS workstation is on the market. The need for PACS integration is clear. "The average hospital performs 150 to 200 chest x-rays a day," states Tim Ketchmark, vice president for EDDA Technology. "Radiologists don't want to break workflow to use the application."
New and upcoming liver, colon and bone densitometry systems were on display. And that's just the beginning. There are prostate solutions in the works and vendors are evaluating lung, liver and kidney systems. Quantifiable measurement of a tumor's response to therapy also is in CAD developers' sights.
CAD Sciences debuted Server 2.4 of its Full-Time-Point MR image post-processing engine and WorkSpace 2.1. Workspace 2.1 offers one-click lesion diagnosis reporting, including graphical and quantitative analysis of tissue biology. A new Therapy Response Monitoring Module monitors a patient's response to cancer therapy.
Confirma showcased CADstream breast MRI CAD solution with access to studies anywhere on a network. Results from a recent University of California, San Francisco, study indicate that automatic volume measurements from CADstream system are predictive of length of recurrence-free survival.
Eastman Kodak Company demonstrated CAD software for its CR-based mammography platforms and for full-field digital mammography (FFDM) systems as works-in-progress. The mammography CAD for the KODAK DIRECTVIEW CR system will be available as a software upgrade for Kodak's current film-based CAD customers.
EDDA Technology launched IQQA-Chest software V2.0 and showcased IQQA-Liver that uses CT images. IQQA-Chest provides an enterprise CAD solution (that instantly deploys from PACS) for digital X-ray and offers real-time interactive diagnostic analysis of digital chest X-rays with tools to support radiologists in their identification, confirmation and quantification of lung nodules.
Guardian Technologies International, Inc. demonstrated Signature Mapping, a methodology and algorithmic process to create distinctive signature maps for organic or inorganic targeted materials. Research is ongoing for detection and quantification of multiple sclerosis lesions, normal pressure hydrocephalus, acute intracranial hemorrhage, tuberculosis, and dense breast tissue.
iCAD, Inc. unveiled SecondLook CAD 7.2 showed its advanced CAD applications in-development for CT colonography. The company also demonstrated improved network connectivity to allow image exchange between clinical systems. A works in progress solution was shown that would improve identification of colonic polyps via virtual colonoscopy.
INFINITT of North America shared INFINITT Lung Solution for lung nodule detection for solid nodules and ground-glass opacity nodules on CT images. Release is slated for early 2007.
Invivo highlighted DynaCAD for breast MR visualization and analysis. The workstation facilitates processing of large digital datasets, generates additional diagnostic information, adds advanced analysis tools and streamlines report workflow.
Medicsight, Inc. launched Medicsight ColonCAR 1.2.1 for use with CT colonography to search for and measure potential colorectal polyps.
Philips Medical Systems introduced its CAD chest solution xLNA (Lung Nodule Assessment) via DR and showed iSite with CT colonography CAD as a work-in-progress. xLNA supports physicians in the visualization, identification, evaluation and reporting of pulmonary nodules as small as 5 mm in digital radiographic chest images. xLNA Enterprise 2.0 will be available in the first quarter of 2007.
Riverain Medical demonstrated further advancements in Rapid≠Screen's sensitivity and specificity and showed lateral CAD chest images to improve the ability to detect early-stage lung cancer.
Siemens Medical Solutions announced FDA approval for its syngo Lung CAD device for use with CT. Syngo Lung CARE CT facilitates comparisons of growth rates and nodule size of detected nodules via automated alignment and volume calculation to support the treatment regimen.